Sharon Mates, Chairman & CEO, Director at Intra-Cellular Therapies, holds 1.07M shares in Intra-Cellular Therapies (Ticker: ITCI). Most recently, Sharon Mates Bought $20,020 shares of Intra-Cellular Therapies on Apr 25, 2024 for an estimated value of 345.62K.